aluates Reports

$ 0.0

Global Personalized Cancer Medicine Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-11F3068

Global Personalized Cancer Medicine Market Insights Forecast to 2028

BUY CHAPTERS

Global Personalized Cancer Medicine Market Research Report 2025

Code: QYRE-Auto-11F3068

Report

March 2025

Pages:92

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Personalized Cancer Medicine Market Size

The global market for Personalized Cancer Medicine was valued at US$ 192390 million in the year 2024 and is projected to reach a revised size of US$ 433640 million by 2031, growing at a CAGR of 12.5% during the forecast period.

Personalized Cancer Medicine Market

Personalized cancer medicine, also known as targeted therapies or precision medicines, are medications designed to specifically target the unique genetic or molecular characteristics of an individual patient"s cancer. These drugs are a central component of personalized cancer medicine and are chosen based on the genomic and molecular profiling of the patient"s tumor.

Immunotherapies: While not traditional targeted therapies, immunotherapies like immune checkpoint inhibitors are another form of personalized cancer treatment. These drugs enhance the patient"s immune system to recognize and attack cancer cells, and they can be tailored to patients based on their tumor"s molecular characteristics.

Personalized cancer treatment drugs have revolutionized cancer care by allowing oncologists to tailor treatment plans to the individual characteristics of each patient"s cancer. This approach holds great promise for improving outcomes and reducing the side effects associated with traditional cancer treatments. However, ongoing research and advancements are needed to expand the repertoire of targeted therapies and ensure that they are accessible to more cancer patients.

In the global market, the core manufacturers of Precision Cancer Medicine (Personalised Cancer Medicine) are AbbVie, Johnson & Johnson, Novartis, and others. The top three players within this industry account for about 30% of the market share. North America, Europe, and Asia Pacific are the major manufacturing regions for this product, with North America accounting for over 50% of the global market share. The product can be classified on the basis of treatment into immunotherapy and targeted therapy drugs. The product is widely used in the treatment of lung, breast, prostate, blood and other cancers.

This report aims to provide a comprehensive presentation of the global market for Personalized Cancer Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Personalized Cancer Medicine.

The Personalized Cancer Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Personalized Cancer Medicine market comprehensively. Regional market sizes, concerning products by Method, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Personalized Cancer Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Method, by Application, and by regions.

Market Segmentation

Scope of Personalized Cancer Medicine Market Report

Report Metric	Details
Report Name	Personalized Cancer Medicine Market
Accounted market size in year	US$ 192390 million
Forecasted market size in 2031	US$ 433640 million
CAGR	12.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Method	Cancer Immunotherapy Targeted Therapy
Segment by Application	Lung Cancer Breast Cancer Prostate Cancer Blood-related Cancer Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AbbVie, Johnson & Johnson, Novartis, Gilead Sciences, Roche, Bristol-Myers Squibb, Amgen, AstraZeneca, Merck & Co, Takeda, Merck KGaA, Seagen, Eli Lilly, Ono Pharmaceutical, Pfizer, GSK, Exelixis, Regeneron, Innovent, Hengrui Medicine
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Method, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Personalized Cancer Medicine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Method, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Personalized Cancer Medicine Market growing?

Ans: The Personalized Cancer Medicine Market witnessing a CAGR of 12.5% during the forecast period 2025-2031.

What is the Personalized Cancer Medicine Market size in 2031?

Ans: The Personalized Cancer Medicine Market size in 2031 will be US$ 433640 million.

What is the market share of major companies in Personalized Cancer Medicine Market?

Ans: The top three players within this industry account for about 30% of the market share.

What is the Personalized Cancer Medicine Market share by region?

Ans: North America, Europe, and Asia Pacific are the major manufacturing regions for this product, with North America accounting for over 50% of the global market share.

Who are the main players in the Personalized Cancer Medicine Market report?

Ans: The main players in the Personalized Cancer Medicine Market are AbbVie, Johnson & Johnson, Novartis, Gilead Sciences, Roche, Bristol-Myers Squibb, Amgen, AstraZeneca, Merck & Co, Takeda, Merck KGaA, Seagen, Eli Lilly, Ono Pharmaceutical, Pfizer, GSK, Exelixis, Regeneron, Innovent, Hengrui Medicine

What are the Application segmentation covered in the Personalized Cancer Medicine Market report?

Ans: The Applications covered in the Personalized Cancer Medicine Market report are Lung Cancer, Breast Cancer, Prostate Cancer, Blood-related Cancer, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Method

1.2.1 Global Personalized Cancer Medicine Market Size Growth Rate by Method: 2020 VS 2024 VS 2031

1.2.2 Cancer Immunotherapy

1.2.3 Targeted Therapy

1.3 Market by Application

1.3.1 Global Personalized Cancer Medicine Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Lung Cancer

1.3.3 Breast Cancer

1.3.4 Prostate Cancer

1.3.5 Blood-related Cancer

1.3.6 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Personalized Cancer Medicine Market Perspective (2020-2031)

2.2 Global Personalized Cancer Medicine Growth Trends by Region

2.2.1 Global Personalized Cancer Medicine Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Personalized Cancer Medicine Historic Market Size by Region (2020-2025)

2.2.3 Personalized Cancer Medicine Forecasted Market Size by Region (2026-2031)

2.3 Personalized Cancer Medicine Market Dynamics

2.3.1 Personalized Cancer Medicine Industry Trends

2.3.2 Personalized Cancer Medicine Market Drivers

2.3.3 Personalized Cancer Medicine Market Challenges

2.3.4 Personalized Cancer Medicine Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Personalized Cancer Medicine Players by Revenue

3.1.1 Global Top Personalized Cancer Medicine Players by Revenue (2020-2025)

3.1.2 Global Personalized Cancer Medicine Revenue Market Share by Players (2020-2025)

3.2 Global Personalized Cancer Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Personalized Cancer Medicine Revenue

3.4 Global Personalized Cancer Medicine Market Concentration Ratio

3.4.1 Global Personalized Cancer Medicine Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Personalized Cancer Medicine Revenue in 2024

3.5 Global Key Players of Personalized Cancer Medicine Head office and Area Served

3.6 Global Key Players of Personalized Cancer Medicine, Product and Application

3.7 Global Key Players of Personalized Cancer Medicine, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Personalized Cancer Medicine Breakdown Data by Method

4.1 Global Personalized Cancer Medicine Historic Market Size by Method (2020-2025)

4.2 Global Personalized Cancer Medicine Forecasted Market Size by Method (2026-2031)

5 Personalized Cancer Medicine Breakdown Data by Application

5.1 Global Personalized Cancer Medicine Historic Market Size by Application (2020-2025)

5.2 Global Personalized Cancer Medicine Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Personalized Cancer Medicine Market Size (2020-2031)

6.2 North America Personalized Cancer Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Personalized Cancer Medicine Market Size by Country (2020-2025)

6.4 North America Personalized Cancer Medicine Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Personalized Cancer Medicine Market Size (2020-2031)

7.2 Europe Personalized Cancer Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Personalized Cancer Medicine Market Size by Country (2020-2025)

7.4 Europe Personalized Cancer Medicine Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Personalized Cancer Medicine Market Size (2020-2031)

8.2 Asia-Pacific Personalized Cancer Medicine Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Personalized Cancer Medicine Market Size by Region (2020-2025)

8.4 Asia-Pacific Personalized Cancer Medicine Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Personalized Cancer Medicine Market Size (2020-2031)

9.2 Latin America Personalized Cancer Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Personalized Cancer Medicine Market Size by Country (2020-2025)

9.4 Latin America Personalized Cancer Medicine Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Personalized Cancer Medicine Market Size (2020-2031)

10.2 Middle East & Africa Personalized Cancer Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Personalized Cancer Medicine Market Size by Country (2020-2025)

10.4 Middle East & Africa Personalized Cancer Medicine Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AbbVie

11.1.1 AbbVie Company Details

11.1.2 AbbVie Business Overview

11.1.3 AbbVie Personalized Cancer Medicine Introduction

11.1.4 AbbVie Revenue in Personalized Cancer Medicine Business (2020-2025)

11.1.5 AbbVie Recent Development

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Details

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Personalized Cancer Medicine Introduction

11.2.4 Johnson & Johnson Revenue in Personalized Cancer Medicine Business (2020-2025)

11.2.5 Johnson & Johnson Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Personalized Cancer Medicine Introduction

11.3.4 Novartis Revenue in Personalized Cancer Medicine Business (2020-2025)

11.3.5 Novartis Recent Development

11.4 Gilead Sciences

11.4.1 Gilead Sciences Company Details

11.4.2 Gilead Sciences Business Overview

11.4.3 Gilead Sciences Personalized Cancer Medicine Introduction

11.4.4 Gilead Sciences Revenue in Personalized Cancer Medicine Business (2020-2025)

11.4.5 Gilead Sciences Recent Development

11.5 Roche

11.5.1 Roche Company Details

11.5.2 Roche Business Overview

11.5.3 Roche Personalized Cancer Medicine Introduction

11.5.4 Roche Revenue in Personalized Cancer Medicine Business (2020-2025)

11.5.5 Roche Recent Development

11.6 Bristol-Myers Squibb

11.6.1 Bristol-Myers Squibb Company Details

11.6.2 Bristol-Myers Squibb Business Overview

11.6.3 Bristol-Myers Squibb Personalized Cancer Medicine Introduction

11.6.4 Bristol-Myers Squibb Revenue in Personalized Cancer Medicine Business (2020-2025)

11.6.5 Bristol-Myers Squibb Recent Development

11.7 Amgen

11.7.1 Amgen Company Details

11.7.2 Amgen Business Overview

11.7.3 Amgen Personalized Cancer Medicine Introduction

11.7.4 Amgen Revenue in Personalized Cancer Medicine Business (2020-2025)

11.7.5 Amgen Recent Development

11.8 AstraZeneca

11.8.1 AstraZeneca Company Details

11.8.2 AstraZeneca Business Overview

11.8.3 AstraZeneca Personalized Cancer Medicine Introduction

11.8.4 AstraZeneca Revenue in Personalized Cancer Medicine Business (2020-2025)

11.8.5 AstraZeneca Recent Development

11.9 Merck & Co

11.9.1 Merck & Co Company Details

11.9.2 Merck & Co Business Overview

11.9.3 Merck & Co Personalized Cancer Medicine Introduction

11.9.4 Merck & Co Revenue in Personalized Cancer Medicine Business (2020-2025)

11.9.5 Merck & Co Recent Development

11.10 Takeda

11.10.1 Takeda Company Details

11.10.2 Takeda Business Overview

11.10.3 Takeda Personalized Cancer Medicine Introduction

11.10.4 Takeda Revenue in Personalized Cancer Medicine Business (2020-2025)

11.10.5 Takeda Recent Development

11.11 Merck KGaA

11.11.1 Merck KGaA Company Details

11.11.2 Merck KGaA Business Overview

11.11.3 Merck KGaA Personalized Cancer Medicine Introduction

11.11.4 Merck KGaA Revenue in Personalized Cancer Medicine Business (2020-2025)

11.11.5 Merck KGaA Recent Development

11.12 Seagen

11.12.1 Seagen Company Details

11.12.2 Seagen Business Overview

11.12.3 Seagen Personalized Cancer Medicine Introduction

11.12.4 Seagen Revenue in Personalized Cancer Medicine Business (2020-2025)

11.12.5 Seagen Recent Development

11.13 Eli Lilly

11.13.1 Eli Lilly Company Details

11.13.2 Eli Lilly Business Overview

11.13.3 Eli Lilly Personalized Cancer Medicine Introduction

11.13.4 Eli Lilly Revenue in Personalized Cancer Medicine Business (2020-2025)

11.13.5 Eli Lilly Recent Development

11.14 Ono Pharmaceutical

11.14.1 Ono Pharmaceutical Company Details

11.14.2 Ono Pharmaceutical Business Overview

11.14.3 Ono Pharmaceutical Personalized Cancer Medicine Introduction

11.14.4 Ono Pharmaceutical Revenue in Personalized Cancer Medicine Business (2020-2025)

11.14.5 Ono Pharmaceutical Recent Development

11.15 Pfizer

11.15.1 Pfizer Company Details

11.15.2 Pfizer Business Overview

11.15.3 Pfizer Personalized Cancer Medicine Introduction

11.15.4 Pfizer Revenue in Personalized Cancer Medicine Business (2020-2025)

11.15.5 Pfizer Recent Development

11.16 GSK

11.16.1 GSK Company Details

11.16.2 GSK Business Overview

11.16.3 GSK Personalized Cancer Medicine Introduction

11.16.4 GSK Revenue in Personalized Cancer Medicine Business (2020-2025)

11.16.5 GSK Recent Development

11.17 Exelixis

11.17.1 Exelixis Company Details

11.17.2 Exelixis Business Overview

11.17.3 Exelixis Personalized Cancer Medicine Introduction

11.17.4 Exelixis Revenue in Personalized Cancer Medicine Business (2020-2025)

11.17.5 Exelixis Recent Development

11.18 Regeneron

11.18.1 Regeneron Company Details

11.18.2 Regeneron Business Overview

11.18.3 Regeneron Personalized Cancer Medicine Introduction

11.18.4 Regeneron Revenue in Personalized Cancer Medicine Business (2020-2025)

11.18.5 Regeneron Recent Development

11.19 Innovent

11.19.1 Innovent Company Details

11.19.2 Innovent Business Overview

11.19.3 Innovent Personalized Cancer Medicine Introduction

11.19.4 Innovent Revenue in Personalized Cancer Medicine Business (2020-2025)

11.19.5 Innovent Recent Development

11.20 Hengrui Medicine

11.20.1 Hengrui Medicine Company Details

11.20.2 Hengrui Medicine Business Overview

11.20.3 Hengrui Medicine Personalized Cancer Medicine Introduction

11.20.4 Hengrui Medicine Revenue in Personalized Cancer Medicine Business (2020-2025)

11.20.5 Hengrui Medicine Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

List of Tables

Table 1. Global Personalized Cancer Medicine Market Size Growth Rate by Method (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Cancer Immunotherapy

Table 3. Key Players of Targeted Therapy

Table 4. Global Personalized Cancer Medicine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Personalized Cancer Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Personalized Cancer Medicine Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Personalized Cancer Medicine Market Share by Region (2020-2025)

Table 8. Global Personalized Cancer Medicine Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Personalized Cancer Medicine Market Share by Region (2026-2031)

Table 10. Personalized Cancer Medicine Market Trends

Table 11. Personalized Cancer Medicine Market Drivers

Table 12. Personalized Cancer Medicine Market Challenges

Table 13. Personalized Cancer Medicine Market Restraints

Table 14. Global Personalized Cancer Medicine Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Personalized Cancer Medicine Market Share by Players (2020-2025)

Table 16. Global Top Personalized Cancer Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Cancer Medicine as of 2024)

Table 17. Ranking of Global Top Personalized Cancer Medicine Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Personalized Cancer Medicine Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Personalized Cancer Medicine, Headquarters and Area Served

Table 20. Global Key Players of Personalized Cancer Medicine, Product and Application

Table 21. Global Key Players of Personalized Cancer Medicine, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Personalized Cancer Medicine Market Size by Method (2020-2025) & (US$ Million)

Table 24. Global Personalized Cancer Medicine Revenue Market Share by Method (2020-2025)

Table 25. Global Personalized Cancer Medicine Forecasted Market Size by Method (2026-2031) & (US$ Million)

Table 26. Global Personalized Cancer Medicine Revenue Market Share by Method (2026-2031)

Table 27. Global Personalized Cancer Medicine Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Personalized Cancer Medicine Revenue Market Share by Application (2020-2025)

Table 29. Global Personalized Cancer Medicine Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Personalized Cancer Medicine Revenue Market Share by Application (2026-2031)

Table 31. North America Personalized Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Personalized Cancer Medicine Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Personalized Cancer Medicine Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Personalized Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Personalized Cancer Medicine Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Personalized Cancer Medicine Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Personalized Cancer Medicine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Personalized Cancer Medicine Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Personalized Cancer Medicine Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Personalized Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Personalized Cancer Medicine Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Personalized Cancer Medicine Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Personalized Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Personalized Cancer Medicine Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Personalized Cancer Medicine Market Size by Country (2026-2031) & (US$ Million)

Table 46. AbbVie Company Details

Table 47. AbbVie Business Overview

Table 48. AbbVie Personalized Cancer Medicine Product

Table 49. AbbVie Revenue in Personalized Cancer Medicine Business (2020-2025) & (US$ Million)

Table 50. AbbVie Recent Development

Table 51. Johnson & Johnson Company Details

Table 52. Johnson & Johnson Business Overview

Table 53. Johnson & Johnson Personalized Cancer Medicine Product

Table 54. Johnson & Johnson Revenue in Personalized Cancer Medicine Business (2020-2025) & (US$ Million)

Table 55. Johnson & Johnson Recent Development

Table 56. Novartis Company Details

Table 57. Novartis Business Overview

Table 58. Novartis Personalized Cancer Medicine Product

Table 59. Novartis Revenue in Personalized Cancer Medicine Business (2020-2025) & (US$ Million)

Table 60. Novartis Recent Development

Table 61. Gilead Sciences Company Details

Table 62. Gilead Sciences Business Overview

Table 63. Gilead Sciences Personalized Cancer Medicine Product

Table 64. Gilead Sciences Revenue in Personalized Cancer Medicine Business (2020-2025) & (US$ Million)

Table 65. Gilead Sciences Recent Development

Table 66. Roche Company Details

Table 67. Roche Business Overview

Table 68. Roche Personalized Cancer Medicine Product

Table 69. Roche Revenue in Personalized Cancer Medicine Business (2020-2025) & (US$ Million)

Table 70. Roche Recent Development

Table 71. Bristol-Myers Squibb Company Details

Table 72. Bristol-Myers Squibb Business Overview

Table 73. Bristol-Myers Squibb Personalized Cancer Medicine Product

Table 74. Bristol-Myers Squibb Revenue in Personalized Cancer Medicine Business (2020-2025) & (US$ Million)

Table 75. Bristol-Myers Squibb Recent Development

Table 76. Amgen Company Details

Table 77. Amgen Business Overview

Table 78. Amgen Personalized Cancer Medicine Product

Table 79. Amgen Revenue in Personalized Cancer Medicine Business (2020-2025) & (US$ Million)

Table 80. Amgen Recent Development

Table 81. AstraZeneca Company Details

Table 82. AstraZeneca Business Overview

Table 83. AstraZeneca Personalized Cancer Medicine Product

Table 84. AstraZeneca Revenue in Personalized Cancer Medicine Business (2020-2025) & (US$ Million)

Table 85. AstraZeneca Recent Development

Table 86. Merck & Co Company Details

Table 87. Merck & Co Business Overview

Table 88. Merck & Co Personalized Cancer Medicine Product

Table 89. Merck & Co Revenue in Personalized Cancer Medicine Business (2020-2025) & (US$ Million)

Table 90. Merck & Co Recent Development

Table 91. Takeda Company Details

Table 92. Takeda Business Overview

Table 93. Takeda Personalized Cancer Medicine Product

Table 94. Takeda Revenue in Personalized Cancer Medicine Business (2020-2025) & (US$ Million)

Table 95. Takeda Recent Development

Table 96. Merck KGaA Company Details

Table 97. Merck KGaA Business Overview

Table 98. Merck KGaA Personalized Cancer Medicine Product

Table 99. Merck KGaA Revenue in Personalized Cancer Medicine Business (2020-2025) & (US$ Million)

Table 100. Merck KGaA Recent Development

Table 101. Seagen Company Details

Table 102. Seagen Business Overview

Table 103. Seagen Personalized Cancer Medicine Product

Table 104. Seagen Revenue in Personalized Cancer Medicine Business (2020-2025) & (US$ Million)

Table 105. Seagen Recent Development

Table 106. Eli Lilly Company Details

Table 107. Eli Lilly Business Overview

Table 108. Eli Lilly Personalized Cancer Medicine Product

Table 109. Eli Lilly Revenue in Personalized Cancer Medicine Business (2020-2025) & (US$ Million)

Table 110. Eli Lilly Recent Development

Table 111. Ono Pharmaceutical Company Details

Table 112. Ono Pharmaceutical Business Overview

Table 113. Ono Pharmaceutical Personalized Cancer Medicine Product

Table 114. Ono Pharmaceutical Revenue in Personalized Cancer Medicine Business (2020-2025) & (US$ Million)

Table 115. Ono Pharmaceutical Recent Development

Table 116. Pfizer Company Details

Table 117. Pfizer Business Overview

Table 118. Pfizer Personalized Cancer Medicine Product

Table 119. Pfizer Revenue in Personalized Cancer Medicine Business (2020-2025) & (US$ Million)

Table 120. Pfizer Recent Development

Table 121. GSK Company Details

Table 122. GSK Business Overview

Table 123. GSK Personalized Cancer Medicine Product

Table 124. GSK Revenue in Personalized Cancer Medicine Business (2020-2025) & (US$ Million)

Table 125. GSK Recent Development

Table 126. Exelixis Company Details

Table 127. Exelixis Business Overview

Table 128. Exelixis Personalized Cancer Medicine Product

Table 129. Exelixis Revenue in Personalized Cancer Medicine Business (2020-2025) & (US$ Million)

Table 130. Exelixis Recent Development

Table 131. Regeneron Company Details

Table 132. Regeneron Business Overview

Table 133. Regeneron Personalized Cancer Medicine Product

Table 134. Regeneron Revenue in Personalized Cancer Medicine Business (2020-2025) & (US$ Million)

Table 135. Regeneron Recent Development

Table 136. Innovent Company Details

Table 137. Innovent Business Overview

Table 138. Innovent Personalized Cancer Medicine Product

Table 139. Innovent Revenue in Personalized Cancer Medicine Business (2020-2025) & (US$ Million)

Table 140. Innovent Recent Development

Table 141. Hengrui Medicine Company Details

Table 142. Hengrui Medicine Business Overview

Table 143. Hengrui Medicine Personalized Cancer Medicine Product

Table 144. Hengrui Medicine Revenue in Personalized Cancer Medicine Business (2020-2025) & (US$ Million)

Table 145. Hengrui Medicine Recent Development

Table 146. Research Programs/Design for This Report

Table 147. Key Data Information from Secondary Sources

Table 148. Key Data Information from Primary Sources

Table 149. Authors List of This Report

List of Figures

Figure 1. Personalized Cancer Medicine Picture

Figure 2. Global Personalized Cancer Medicine Market Size Comparison by Method (2020-2031) & (US$ Million)

Figure 3. Global Personalized Cancer Medicine Market Share by Method: 2024 VS 2031

Figure 4. Cancer Immunotherapy Features

Figure 5. Targeted Therapy Features

Figure 6. Global Personalized Cancer Medicine Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Personalized Cancer Medicine Market Share by Application: 2024 VS 2031

Figure 8. Lung Cancer Case Studies

Figure 9. Breast Cancer Case Studies

Figure 10. Prostate Cancer Case Studies

Figure 11. Blood-related Cancer Case Studies

Figure 12. Other Case Studies

Figure 13. Personalized Cancer Medicine Report Years Considered

Figure 14. Global Personalized Cancer Medicine Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Personalized Cancer Medicine Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Personalized Cancer Medicine Market Share by Region: 2024 VS 2031

Figure 17. Global Personalized Cancer Medicine Market Share by Players in 2024

Figure 18. Global Top Personalized Cancer Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Cancer Medicine as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Personalized Cancer Medicine Revenue in 2024

Figure 20. North America Personalized Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Personalized Cancer Medicine Market Share by Country (2020-2031)

Figure 22. United States Personalized Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Personalized Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Personalized Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Personalized Cancer Medicine Market Share by Country (2020-2031)

Figure 26. Germany Personalized Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Personalized Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Personalized Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Personalized Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Personalized Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Personalized Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Personalized Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Personalized Cancer Medicine Market Share by Region (2020-2031)

Figure 34. China Personalized Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Personalized Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Personalized Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Personalized Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Personalized Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Personalized Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Personalized Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Personalized Cancer Medicine Market Share by Country (2020-2031)

Figure 42. Mexico Personalized Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Personalized Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Personalized Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Personalized Cancer Medicine Market Share by Country (2020-2031)

Figure 46. Turkey Personalized Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Personalized Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Personalized Cancer Medicine Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. AbbVie Revenue Growth Rate in Personalized Cancer Medicine Business (2020-2025)

Figure 50. Johnson & Johnson Revenue Growth Rate in Personalized Cancer Medicine Business (2020-2025)

Figure 51. Novartis Revenue Growth Rate in Personalized Cancer Medicine Business (2020-2025)

Figure 52. Gilead Sciences Revenue Growth Rate in Personalized Cancer Medicine Business (2020-2025)

Figure 53. Roche Revenue Growth Rate in Personalized Cancer Medicine Business (2020-2025)

Figure 54. Bristol-Myers Squibb Revenue Growth Rate in Personalized Cancer Medicine Business (2020-2025)

Figure 55. Amgen Revenue Growth Rate in Personalized Cancer Medicine Business (2020-2025)

Figure 56. AstraZeneca Revenue Growth Rate in Personalized Cancer Medicine Business (2020-2025)

Figure 57. Merck & Co Revenue Growth Rate in Personalized Cancer Medicine Business (2020-2025)

Figure 58. Takeda Revenue Growth Rate in Personalized Cancer Medicine Business (2020-2025)

Figure 59. Merck KGaA Revenue Growth Rate in Personalized Cancer Medicine Business (2020-2025)

Figure 60. Seagen Revenue Growth Rate in Personalized Cancer Medicine Business (2020-2025)

Figure 61. Eli Lilly Revenue Growth Rate in Personalized Cancer Medicine Business (2020-2025)

Figure 62. Ono Pharmaceutical Revenue Growth Rate in Personalized Cancer Medicine Business (2020-2025)

Figure 63. Pfizer Revenue Growth Rate in Personalized Cancer Medicine Business (2020-2025)

Figure 64. GSK Revenue Growth Rate in Personalized Cancer Medicine Business (2020-2025)

Figure 65. Exelixis Revenue Growth Rate in Personalized Cancer Medicine Business (2020-2025)

Figure 66. Regeneron Revenue Growth Rate in Personalized Cancer Medicine Business (2020-2025)

Figure 67. Innovent Revenue Growth Rate in Personalized Cancer Medicine Business (2020-2025)

Figure 68. Hengrui Medicine Revenue Growth Rate in Personalized Cancer Medicine Business (2020-2025)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Kidney Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-38R2107

Fri Mar 14 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Radiotherapy Positioning Products Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34T16080

Fri Mar 14 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Radiation Oncology Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35A12535

Thu Mar 13 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Kidney Cancer Targeted Therapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-24A14985

Thu Mar 13 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Personalized Cancer Medicine Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-11F3068

Global Personalized Cancer Medicine Market Research Report 2025

FEATURED COMPANIES

Personalized Cancer Medicine Market Size

Personalized Cancer Medicine Market

Scope of Personalized Cancer Medicine Market Report

Chapter Outline

FAQ for this report

How fast is Personalized Cancer Medicine Market growing?

What is the Personalized Cancer Medicine Market size in 2031?

What is the market share of major companies in Personalized Cancer Medicine Market?

What is the Personalized Cancer Medicine Market share by region?

Who are the main players in the Personalized Cancer Medicine Market report?

What are the Application segmentation covered in the Personalized Cancer Medicine Market report?

FEATURED COMPANIES

RELATED REPORTS

$5800

Enterprise User

$5800

Enterprise User

$5800

Enterprise User

$5800

Enterprise User